Formation of CDSCO’s New Intelligence Cell to keep check Illegal Activity In country’s Pharma Sector

To check illegal activities in India’s pharma sector, India’s central drug regulator CDSCO (The Central Drugs Standard Control Organisation) has formed intelligence cell of nine-member. This new cell aims to track illegal activity in the country’s pharmaceutical sector.

According to the officials, the cell has the authority to gather data on the import and export of medicines and cosmetics against the law and investigating complaints related to medicine quality received from overseas regulatory agencies.

This cell will keep tracking and check all the activities carried out in contravention to the provisions of the Drugs & Cosmetics Act, 1940, stated the order and cell will be in charge of collecting and collating information based on that.

The cell also has permissions to assist in raids in collaboration with zonal and sub-zonal offices.

Related Posts

CDSCO releases MedTech Mitra’s handbook

New Delhi: The Central Drugs Standard Control Organisation (CDSCO), in collaboration with Indian Council of Medical Research (ICMR), has released the MedTech Mitra’s handbook for innovators in the in-vitro diagnostics…

Telangana Rising Vision Document Aims for USD 3 Trillion Economy

Hyderabad: Telangana Chief Minister A Revanth Reddy has introduced the Telangana Rising vision document, which aims to transform the state into a USD three trillion economy by 2047. This announcement…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CDSCO releases MedTech Mitra’s handbook

CDSCO releases MedTech Mitra’s handbook

Telangana Rising Vision Document Aims for USD 3 Trillion Economy

Telangana Rising Vision Document Aims for USD 3 Trillion Economy

Novo moves court to restrain Sun Pharma, Alkem from manufacture, sale of Semaglutide

Novo moves court to restrain Sun Pharma, Alkem from manufacture, sale of Semaglutide

Strides Pharma names Nandini Matiyani Global Head of HR

Strides Pharma names Nandini Matiyani Global Head of HR

Novo Nordisk now wants Sun Pharma to stop dealing in weight loss drug compound, goes to Delhi HC again

Novo Nordisk now wants Sun Pharma to stop dealing in weight loss drug compound, goes to Delhi HC again

Dr Reddy’s inks licensing deal to sell Immutep’s cancer drug

Dr Reddy’s inks licensing deal to sell Immutep’s cancer drug